NCT04070222

Brief Summary

Mode of delivery affects the success rate of assisted reproductive techniques (ART). In this case study, the investigators will evaluate changes in the bacterial ecology and inflammatory markers of the female uterus with different delivery modes. We will investigate whether the dominate endometrial microflora is interrupted by the Cesarean section in the infertile women undergoing ART, and the potential mechanism will also be further explored prospectively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2019

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

December 24, 2019

Status Verified

December 1, 2019

Enrollment Period

3 years

First QC Date

August 22, 2019

Last Update Submit

December 21, 2019

Conditions

Keywords

Secondary infertility, cesarean section, post-cesarean section scar diverticulum , endometrial microflora, inflammatory markers, clinical pregnancy, live birth

Outcome Measures

Primary Outcomes (2)

  • Species and communities of uterine microflora

    Use the swab to scrape endometrium. Characterization of species and communities of uterine microflora will use bacterial DNA microarray analysis. Normally, the uterine cavity used to being thought a sterile space.

    1-2 year

  • Inflammatory markers of the female uterus

    Use the swab to scrape endometrium. Characterization of inflammatory markers of the female uterus will use human cytokines measuring. The cytokines will include IL2,IL4,SDF-1α , etc. Use the natural labor group as control group, and see differentiation among the three group.

    1-2 year

Secondary Outcomes (4)

  • Clinical pregnancy rate

    1-2 year

  • Biochemical pregnancy rate

    1-2 year

  • Embryo implantation rate

    1-2 year

  • Live birth rate

    1-2 year

Study Arms (3)

Natural labour group

Other: Hysteroscopy

Cesarean scar group

Other: Hysteroscopy

Cesarean with diverticulum (PCSD) group

Other: Hysteroscopy

Interventions

1. Three groups of patients will be enrolled: Natural labour group, Cesarean scar group and Cesarean with diverticulum (PCSD) group; 2. Hysteroscopy will be carried out for uterine cavity examine and the specimen collection for further microflora analysis and inflammation marker detection; 3. ART will be carried out with standard protocol and the clinical outcome will be recorded; 4. The primary outcome of the study is the comparation of species and communities of uterine microflora and inflammatory markers of the female uterus among three groups. The secondary outcome is biochemical pregnancy rate, clinical pregnancy rate, embryo implantation rate and live birth rate.

Also known as: assisted reproductive medicine
Cesarean scar groupCesarean with diverticulum (PCSD) groupNatural labour group

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Infertile patients who had live birth previously and met the criteria, required for IVF treatment from Aug 2019 to Aug 2022 in our center.

You may qualify if:

  • Women age ≥20 years and ≤40 years.
  • infertile Women with previously live birth.
  • Previous failed transfer cycle ≤2
  • Didn't participate in other clinical subjects within three months.
  • Written informed consent.

You may not qualify if:

  • surgery history including: Ovariectomy, myomectomy, adenomyomectomy.
  • Uterine diseases including: uterine malformation, submucosal uterine fibroids and intrauterine adhesion.
  • One of couple has abnormal karyotype.
  • Recurrent abortion ≥2.
  • Untreated hydrosalpinx.
  • History of tuberculosis (pulmonary tuberculosis, pelvic tuberculosis etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Sixth Affiliated Hospital,Sun Yat-Sen University

Guandong, China

RECRUITING

MeSH Terms

Interventions

Hysteroscopy

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeObstetric Surgical ProceduresGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Xing Yang, M.D. & Ph.D

    The Sixth Affiliated Hospital, Sun Yat-sen University

    STUDY CHAIR
  • Xaoyan Liang, M.D. & Ph.D

    The Sixth Affiliated Hospital, Sun Yat-sen University

    STUDY DIRECTOR

Central Study Contacts

Xing Yang, M.D. & Ph.D

CONTACT

Xing Yang, M.D. & Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 22, 2019

First Posted

August 28, 2019

Study Start

August 1, 2019

Primary Completion

August 1, 2022

Study Completion

April 1, 2023

Last Updated

December 24, 2019

Record last verified: 2019-12

Locations